The transcription factor nuclear factor-erythroid 2 p45-related factor 2 (Nrf2, with gene called NFE2L2) is a master regulator of the antioxidant response. In the last decade, interest has intensified in this research area as its importance in several physiological and pathological processes has become widely recognized; these include redox signalling and redox homoeostasis, drug metabolism and disposition, intermediary metabolism, cellular adaptation to stress, chemoprevention and chemoresistance, toxicity, inflammation, neurodegeneration, lipogenesis and aging. Regulation of Nrf2 is complex and although much attention has focussed on its repression by Kelch-like ECH-associated protein-1 (Keap1), recently it has become increasingly apparent that it is also controlled by cross-talk with other signalling pathways including the glycogen synthase kinase-3 (GSK-3)−β-transducin repeat-containing protein (β-TrCP) axis, ERAD (endoplasmic reticulum-associated degradation)-associated E3 ubiquitin-protein ligase (Hrd1, also called synoviolin), nuclear factor-kappa B (NF-κB), Notch and AMP kinase. Due to its beneficial role in several diseases, Nrf2 has become a major therapeutic target, with novel natural, synthetic and targeted small molecules currently under investigation to modulate the pathway and in clinical trials.
Skip Nav Destination
Article navigation
August 2015
- Cover Image
- PDF Icon PDF LinkTable of Contents
Review Article|
August 03 2015
The Keap1/Nrf2 pathway in health and disease: from the bench to the clinic
Maria A. O’Connell;
Maria A. O’Connell
1
*School of Pharmacy, University of East Anglia, Norwich Research Park, Norwich, NR4 7TJ, U.K.
1To whom correspondence should be addressed (emailm.oconnell@uea.ac.uk).
Search for other works by this author on:
John D. Hayes
John D. Hayes
†Jacqui Wood Cancer Centre, Division of Cancer Research, Medical Research Institute, Ninewells Hospital and Medical School, University of Dundee, Dundee DD1 9SY, U.K.
Search for other works by this author on:
Biochem Soc Trans (2015) 43 (4): 687–689.
Article history
Received:
April 01 2015
Citation
Maria A. O’Connell, John D. Hayes; The Keap1/Nrf2 pathway in health and disease: from the bench to the clinic. Biochem Soc Trans 1 August 2015; 43 (4): 687–689. doi: https://doi.org/10.1042/BST20150069
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.